Aug 11,2021

Mahana Therapeutics Secures $61 Million Series B Financing to Support Commercialization and Further Development of Digital Therapeutics

Mahana Therapeutics, a leading developer of prescription digital therapeutics designed to empower patients with chronic health conditions, has completed a $61 million Series B financing. The company will use the funds to launch the FDA-cleared prescription digital therapeutic Mahana™ IBS and accelerate development of several digital therapeutics for chronic health conditions.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Oct 22,2021

DTx company Click Therapeutic scores $52M in Series B funding

This morning prescription digital therapeutic company Click Therapeutic announced a $52 million Series B funding round. H.I.G. BioHealth Partners and Accelmed Partners ll led the round, with participation from Health Catalyst Capital, Revelation Partners, Sanofi, K2 HealthVentures, Hima Ventures and RdigetopHealth. This news comes over a year after the company inked a $500 million-plus deal with pharma company Boehringer Ingelheim to jointly commercialize a digital treatment for patients with schizophrenia.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Nov 11,2021

AppliedVR scores $36M for virtual reality pain management

AppliedVR, developer of virtual reality therapeutics, has scooped up $36 million in Series B funding months after it closed a Series A round. The Series B, which included investments from F-Prime Capital, JAZZ Venture Partners, Sway Ventures and SVB Ventures, brought the company’s total raise to $71 million. AppliedVR creates virtual reality technology for healthcare applications, with platforms in its pipeline for chronic pain management, acute postoperative pain and anxiety.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Nov 16,2021

MedRhythms Announces Addition of Global Brain Corporation and Bose Ventures to Series B Round

MedRhythms, a leader in developing prescription digital therapeutics that use sensors, software, and music to measure and improve walking for patients with a neurologic injury or disease, today announced the closing of a Series B extension round, with investment from one of Japan's largest venture capital companies Global Brain with its CVC JGC MIRAI Innovation Fund, and Bose Ventures. The follow-on investment brings the Company’s total Series B financing to $27 million, an increase from their announcement in July.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Nov 29,2021

ieso Raises $53 Million to Address Global Mental Health Crisis With Digital Therapeutics

ieso, a UK leader in digital mental healthcare, announces the completion of its $53 million Series B financing round led by investment firm Morningside, with further new investment from Sony Innovation Fund and existing shareholders IP Group, Molten Ventures and Ananda Impact Ventures.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Dec 02,2021

Digital insulin management company Hygieia closes on $17 million Series B investment round

Hygieia, a digital health company for insulin management, has closed on an initial $17 million Series B investment round, led by Israeli venture capital firm Firstime Ventures, and with participation from existing investors. Hygieia will use the funding to expand partnerships with endocrinology practices and expand access to its unique d-Nav® insulin dose automation technology for people with type 2 diabetes.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 04,2022

Sidekick Health grabs $55M for digital-first care programs

Iceland’s Sidekick Health has developed a gamified digital care platform that’s designed to support healthcare outcomes by applying personalized behavioral lifestyle nudges, including alongside clinical treatments like drugs, to augment, extend and support patient care for a range of chronic diseases and conditions from cancer to cardiovascular health, diabetes and arthritis — a formula that’s now scored it $55 million in Series B growth funding. The new round is led by London-based VC firm Novator Ventures, with participation from Wellington Partners, Asabys Partners and Frumtak Ventures, as well as a U.S.-based strategic investor which it’s not disclosing yet but says will be revealed at a later stage.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jan 22,2021

OncoHost Secures $8 Million Series B Funding Round

OncoHost, a global leader in technology involving host response profiling and personalized cancer therapy, has completed a $8 million Series B funding round. The new funding will help advance the company’s AI-powered precision oncology platform.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Apr 23,2020

Paige adds $5M from Goldman Sachs to double down on AI-based cancer therapies

Paige, the Sloan-Kettering spinout that has been building an artificial intelligence platform to improve cancer pathology and subsequently use those insights to develop better drug therapies, has raised an additional $5 million in funding to continue its work commercialising its platform and expanding its research reach, while also getting FDA clearance to launch in hospitals in North America and Europe.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jun 04,2020

Nanox, maker of a low-cost scanning service to replace X-rays, expands Series B to $51M

Nanox, a startup out of Israel that has developed a small, low-cost scanning system and “medical screening as a service” to replace the costly and large machines and corresponding software typically used for X-rays, CAT scans, PET scans and other body imaging services, is today announcing that it has raised $20 million from a strategic investor, South Korean carrier SK Telecom. The funding is technically an extension of Nanox’s previous round, which was announced earlier this year at $26 million with backing from Foxconn, FujiFilm and more. Nanox says that the full round is now closed off at $51 million, with the company having raised $80 million since launching almost a decade ago, in 2011.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Subscribe to SERIES B